Latest News in the pharma Industry

Biopharma News

Mylan and Biocon announce regulatory submission for proposed biosimilar Pegfilgrastim accepted for review by EMA

Mylan and Biocon announce regulatory submission for proposed biosimilar Pegfilgrastim accepted for review by EMA

21 Jul 2016

Read more 
SB5, an adalimumab biosimilar referencing Humira, accepted for review by EMA

SB5, an adalimumab biosimilar referencing Humira, accepted for review by EMA

18 Jul 2016

The approval of SB5 could make Biogen the first company to commercialize three anti-TNF biosimilar therapies in Europe.

Read more 
Merck relaunches customer collaboration centers with new concept and M Lab name

Merck relaunches customer collaboration centers with new concept and M Lab name

18 Jul 2016

Enables explorations of new technologies and solutions to address development and manufacturing challenges.

Read more 
Cipla to launch South Africa’s first biotech manufacturing facility

Cipla to launch South Africa’s first biotech manufacturing facility

12 Jul 2016

The plant will manufacture biosimilars and construction is scheduled to start in early 2017, with full operations expected to commence in the third quarter of 2018.

Read more 
Sartorius Stedim BioOutsource introduces new Released N-Glycan Assay

Sartorius Stedim BioOutsource introduces new Released N-Glycan Assay

7 Jul 2016

In-depth profiling of IgG glycosylation coupled with ADCC assays enables generation of robust biosimilar comparability data.

Read more 
Sartorius Stedim Biotech acquires US start-up kSep Systems

Sartorius Stedim Biotech acquires US start-up kSep Systems

6 Jul 2016

Transaction to expand SSB’s bioprocessing product portfolio with innovative single-use centrifuges.

Read more 
LEO Pharma enters biologics through strategic partnership with AstraZeneca

LEO Pharma enters biologics through strategic partnership with AstraZeneca

1 Jul 2016

The partnership covers potential new medicines for atopic dermatitis and psoriasis.

Read more 
Pfizer invests in a new world-class global biotechnology center in China

Pfizer invests in a new world-class global biotechnology center in China

28 Jun 2016

State-of-the-art facility will foster the continued development of the biotechnology industry in China, further supporting national healthcare reforms.

Read more 
Sandoz announces plans for five major global biosimilar launches by 2020

Sandoz announces plans for five major global biosimilar launches by 2020

26 Jun 2016

Investments of more than USD 1 billion in state of-the-art biomanufacturing facilities, backed by industry-leading capabilities as part of Novartis, positions Sandoz to deliver biosimilars at unprecedented scale.

Read more 
Sartorius Stedim Biotech launches innovative ambr 250 modular bioreactor system

Sartorius Stedim Biotech launches innovative ambr 250 modular bioreactor system

15 Jun 2016

New expandable benchtop workstation with unique single-use bioreactor design offers a simple approach to process development for fermentation and cell culture.

Read more 
New Sartorius Stedim BioOutsource microsite goes live

New Sartorius Stedim BioOutsource microsite goes live

14 Jun 2016

Cellca’s cell line and upstream process development services now integrated.

Read more 
Health Canada approves Inflectra (biosimilar infliximab) for three additional indications

Health Canada approves Inflectra (biosimilar infliximab) for three additional indications

14 Jun 2016

The addition of Crohn's disease, fistulising Crohn's disease and ulcerative colitis to the approved indications was granted on the basis of similarity between Inflectra and the reference product, Remicade.

Read more